Cargando…
A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium
The contrast-induced acute kidney injury (CI-AKI) has been becoming the third common cause of hospital-acquired acute kidney injury. An ideal animal model is essential for understanding the pathophysiology of CI-AKI. Previous CI-AKI studies were mostly performed on rats with high-osmolar contrast me...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367657/ https://www.ncbi.nlm.nih.gov/pubmed/35938700 http://dx.doi.org/10.1080/0886022X.2022.2108449 |
_version_ | 1784765874669879296 |
---|---|
author | Wu, Jiajia Shen, Jianxiao Wang, Wanpeng Jiang, Na Jin, Haijiao Che, Xiajing Ni, Zhaohui Fang, Yan Mou, Shan |
author_facet | Wu, Jiajia Shen, Jianxiao Wang, Wanpeng Jiang, Na Jin, Haijiao Che, Xiajing Ni, Zhaohui Fang, Yan Mou, Shan |
author_sort | Wu, Jiajia |
collection | PubMed |
description | The contrast-induced acute kidney injury (CI-AKI) has been becoming the third common cause of hospital-acquired acute kidney injury. An ideal animal model is essential for understanding the pathophysiology of CI-AKI. Previous CI-AKI studies were mostly performed on rats with high-osmolar contrast medium (HOCM), which is unsuitable for transgenic researches. This study provides a novel, efficient and reproducible CI-AKI model which was developed in mouse by administrating a low-osmolar contrast medium (LOCM). First of all, we applied the frequently used pretreatments (uninephrectomy and water deprivation), which combined with HOCM on rats could induce CI-AKI, on mice with LOCM. Secondly, we attempted to find a novel pretreatment suitable for mouse and LOCM by combining two classic pretreatments(uninephrectomy, water deprivation and furosemide administration). Finally, we evaluate the kidney damage of the novel model. We found that this mouse model possessed a significant reduction in renal function, severe renal tissue damage, and increased renal tubular cells apoptosis, indicating that LOCM is a feasible inducer for CI-AKI mice model. Taken together, we found that uninephrectomy (UPHT) combined with 24 h water deprivation and furosemide administration 20 min before LOCM (iohexol, 10 ml/kg) application is a feasible pretreatment to establish a novel CI-AKI mouse model. |
format | Online Article Text |
id | pubmed-9367657 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-93676572022-08-12 A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium Wu, Jiajia Shen, Jianxiao Wang, Wanpeng Jiang, Na Jin, Haijiao Che, Xiajing Ni, Zhaohui Fang, Yan Mou, Shan Ren Fail Research Article The contrast-induced acute kidney injury (CI-AKI) has been becoming the third common cause of hospital-acquired acute kidney injury. An ideal animal model is essential for understanding the pathophysiology of CI-AKI. Previous CI-AKI studies were mostly performed on rats with high-osmolar contrast medium (HOCM), which is unsuitable for transgenic researches. This study provides a novel, efficient and reproducible CI-AKI model which was developed in mouse by administrating a low-osmolar contrast medium (LOCM). First of all, we applied the frequently used pretreatments (uninephrectomy and water deprivation), which combined with HOCM on rats could induce CI-AKI, on mice with LOCM. Secondly, we attempted to find a novel pretreatment suitable for mouse and LOCM by combining two classic pretreatments(uninephrectomy, water deprivation and furosemide administration). Finally, we evaluate the kidney damage of the novel model. We found that this mouse model possessed a significant reduction in renal function, severe renal tissue damage, and increased renal tubular cells apoptosis, indicating that LOCM is a feasible inducer for CI-AKI mice model. Taken together, we found that uninephrectomy (UPHT) combined with 24 h water deprivation and furosemide administration 20 min before LOCM (iohexol, 10 ml/kg) application is a feasible pretreatment to establish a novel CI-AKI mouse model. Taylor & Francis 2022-08-08 /pmc/articles/PMC9367657/ /pubmed/35938700 http://dx.doi.org/10.1080/0886022X.2022.2108449 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Wu, Jiajia Shen, Jianxiao Wang, Wanpeng Jiang, Na Jin, Haijiao Che, Xiajing Ni, Zhaohui Fang, Yan Mou, Shan A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium |
title | A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium |
title_full | A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium |
title_fullStr | A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium |
title_full_unstemmed | A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium |
title_short | A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium |
title_sort | novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367657/ https://www.ncbi.nlm.nih.gov/pubmed/35938700 http://dx.doi.org/10.1080/0886022X.2022.2108449 |
work_keys_str_mv | AT wujiajia anovelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium AT shenjianxiao anovelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium AT wangwanpeng anovelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium AT jiangna anovelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium AT jinhaijiao anovelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium AT chexiajing anovelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium AT nizhaohui anovelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium AT fangyan anovelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium AT moushan anovelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium AT wujiajia novelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium AT shenjianxiao novelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium AT wangwanpeng novelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium AT jiangna novelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium AT jinhaijiao novelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium AT chexiajing novelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium AT nizhaohui novelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium AT fangyan novelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium AT moushan novelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium |